Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
11.12
+0.70 (6.72%)
At close: Oct 28, 2026, 4:00 PM EDT
11.00
-0.12 (-1.08%)
After-hours: Oct 28, 2026, 7:42 PM EDT
Turn Therapeutics Market Cap
Turn Therapeutics has a market cap or net worth of $331.24 million as of October 28, 2026. It is the 17,396th most valuable company in the world and the 3,092nd biggest in the United States. Its market cap has increased by 137.84% in one year.
Market Cap
331.24M
Enterprise Value
327.08M
1-Year Change
137.84%
Global Rank
Country Rank
#3,092 United States
Category
ChartMarket Cap Chart
Since October 8, 2025, Turn Therapeutics's market cap has increased from $196.16M to $331.24M, an increase of 68.86%. That is a compound annual growth rate of 64.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 331.24M | 185.52% |
| Dec 31, 2025 | 116.01M | -40.86% |
| Oct 8, 2025 | 196.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 332.01M |
| Atea Pharmaceuticals | 331.25M |
| Galectin Therapeutics | 330.28M |
| vTv Therapeutics | 319.69M |
| X4 Pharmaceuticals | 318.26M |
| Arcturus Therapeutics Holdings | 310.10M |
| Eikon Therapeutics | 309.28M |
| Vogenx | 304.83M |